PL416613A1 - New heterocyclic compounds and method for obtaining them - Google Patents

New heterocyclic compounds and method for obtaining them

Info

Publication number
PL416613A1
PL416613A1 PL416613A PL41661316A PL416613A1 PL 416613 A1 PL416613 A1 PL 416613A1 PL 416613 A PL416613 A PL 416613A PL 41661316 A PL41661316 A PL 41661316A PL 416613 A1 PL416613 A1 PL 416613A1
Authority
PL
Poland
Prior art keywords
obtaining
heterocyclic compounds
new heterocyclic
substituent
application
Prior art date
Application number
PL416613A
Other languages
Polish (pl)
Inventor
Daniel Gryko
Maciej Krzeszewski
Original Assignee
Instytut Chemii Organicznej Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Chemii Organicznej Polskiej Akademii Nauk filed Critical Instytut Chemii Organicznej Polskiej Akademii Nauk
Priority to PL416613A priority Critical patent/PL416613A1/en
Publication of PL416613A1 publication Critical patent/PL416613A1/en

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest związek o wzorze I, gdzie: R1 oznacza atom wodoru lub podstawnik wybrany spośród: -CN, -CO2Me, -CO2Et, -SO3H, -CHO, -CONH2, F, Cl, Br, I, -NO2, -OMe, -NH2 lub -Nme2, R2 oznacza podstawnik alifatyczny lub atom wodoru, X oznacza podstawnik aromatyczny lub heteroaromatyczny. Zgłoszenie obejmuje także sposób otrzymywania powyższego związku.The subject of the application is a compound of formula I, where: R1 is a hydrogen atom or a substituent selected from: -CN, -CO2Me, -CO2Et, -SO3H, -CHO, -CONH2, F, Cl, Br, I, -NO2, -OMe , -NH2 or -Nme2, R2 is an aliphatic substituent or hydrogen, X is an aromatic or heteroaromatic substituent. The application also includes a method of obtaining the above compound.

PL416613A 2016-03-24 2016-03-24 New heterocyclic compounds and method for obtaining them PL416613A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL416613A PL416613A1 (en) 2016-03-24 2016-03-24 New heterocyclic compounds and method for obtaining them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL416613A PL416613A1 (en) 2016-03-24 2016-03-24 New heterocyclic compounds and method for obtaining them

Publications (1)

Publication Number Publication Date
PL416613A1 true PL416613A1 (en) 2017-09-25

Family

ID=59897609

Family Applications (1)

Application Number Title Priority Date Filing Date
PL416613A PL416613A1 (en) 2016-03-24 2016-03-24 New heterocyclic compounds and method for obtaining them

Country Status (1)

Country Link
PL (1) PL416613A1 (en)

Similar Documents

Publication Publication Date Title
MX374439B (en) PYRIDONE COMPOUND AS A C-MET INHIBITOR
ZA202101788B (en) Aminopyrimidine/pyrazine derivatives as ctps1 inhibitors
CR20180072A (en) NEW BICYCLE COMPOUNDS AS ATX INHIBITORS
PH12017502090A1 (en) Heterocyclic amides as kinase inhibitors
CR20180057A (en) NEW BICYCLE COMPOUNDS AS DUAL INHIBITORS OF ATX / CA.
SG11202011513RA (en) Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof
MX2020009887A (en) Aminopyrimidine derivatives as ctps1 inhibitors.
MX362582B (en) Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors.
CL2019002609A1 (en) Heterocyclic compounds useful as double atx / ca inhibitors.
MX2018007421A (en) Tank-binding kinase inhibitor compounds.
EA201791563A1 (en) SUBSTITUTED NUCLEOSIDE DERIVATIVES, USEFUL AS AN AGENT AGAINST CANCER
EA202192151A1 (en) USE OF PYRAZOLE PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-RELATED DISORDERS
UY35485A (en) HETEROCYCLIC COMPOUNDS AND USES OF THE SAME
MX341446B (en) Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors.
EA201591503A1 (en) NAFTHYRIDINE DERIVATIVES, USEFUL AS ANTAGONISTS ALPHA-V-BETA-6 INTEGRINA
PE20181288A1 (en) DIHYDROIMIDAZOPYRAZINONE DERIVATIVES USED IN THE TREATMENT OF CANCER
MX2017003930A (en) Aminotriazine derivatives useful as tank-binding kinase inhibitor compounds.
CR20180143A (en) NEW BICYCLE COMPOUNDS AS DUAL INHIBITORS OF ATX / CA
CY1122423T1 (en) PYRIMIDINE DERIVATIVES USABLE AS SELECTIVE JAK3 AND/OR JAK1 INHIBITORS
PH12015502611A1 (en) Heterocyclic compounds as hedgehog signaling pathway inhibitors
CL2019002662A1 (en) Ip6k inhibitors.
JO3261B1 (en) Mono - pyridine derivative
MY184218A (en) 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide derivatives and their use as phd inhibitors
JO3793B1 (en) Proton tyrosine kinase inhibitors and how to use them
EA201690523A1 (en) TRIAZOLOPIRIDIN, COMPOSITIONS AND METHODS OF THEIR APPLICATION